PTHLH and breast carcinoma: In a large analysis including two genome-wide association studies from 41 case–control studies through the Breast Cancer Association Consortium (BCAC) and nine breast cancer genome-wide association studies, PTHLH was identified as a susceptibility locus in both ER+ and ER− breast cancer (149).